This page shows the latest Asthma UK news and features for those working in and with pharma, biotech and healthcare.
An estimated 98, 000 patients with severe uncontrolled asthma may be eligible for the new treatment. ... Tom Keith-Roach, president of AZ UK, said: “This is an important step towards [Tezspire] being considered for use in the treatment of eligible UK
Ian Pavord, professor of respiratory medicine at the University of Oxford said: “In the UK, asthma attacks remain a major burden in patients diagnosed with mild asthma and these are driven ... 200/6 as an important new treatment option for patients
News from pharma, biotech and healthcare. Limited NICE approval for AZ’s asthma drug Fasenra. ... However, the UK's cost-effectiveness watchdog says the drug should only be used in limited circumstances for eosinophilic asthma, when usual therapies
The UK is welcoming a new set of national standards this coming year, which are designed to improve the quality and consistency of public involvement in research. ... The standards will be launched across ten pilot sites in the UK including Asthma UK
Teva's interleukin-5 (IL-5) inhibitor should be made available to patients under the NHS as an add-on therapy for patients with for severe eosinophilic asthma, says the ... Kay Boycott, chief executive of medical charity Asthma UK, welcomed the decision.
According to Asthma UK's Annual Asthma Survey 2016 report, emergency hospital admission is 23 times more expensive than an asthma review, with the annual cost of asthma care in the ... It is shocking that [according to Asthma UK's report] 82% of UK
More from news
Approximately 3 fully matching, plus 19 partially matching documents found.
Prior to The NSMC, Patrick worked in the voluntary sector for ten years, initially in fundraising with Barnardos and VSO, and then at Asthma UK leading their Children and Young
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
No results were found
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...